Reported 2 days ago
The Trump administration is engaging with pharmaceutical companies to reform pharmacy benefit managers (PBMs) in response to growing concerns over drug prices. Senior Health Reporter Anjalee Khemlani discusses the implications of PBMs as intermediaries on consumer choices and the potential for cost savings in pharmaceuticals.
Source: YAHOO